DiaMedica’s CMO Hire: Next-Stage Trial Deal
Julie Krop joins as CMO at DiaMedica. Trigger clinical trial management & regulatory consulting pitches. Fill your pipeline and crush quota.
Published on
Do not index
Do not index
🚀 Battle Card: DiaMedica Therapeutics Inc.
Quick trigger:
👤 Decision Maker in the News
- Julie Krop, MD, Chief Medical Officer
💡 Why It Matters
- Flag this DiaMedica Therapeutics Inc. sales trigger: bringing in a veteran biopharma CMO signals a full-court press toward late-stage trials and FDA filings for DM199 → Source
🎯 Core Pain Point
- Complexity of orphan and acute ischemic stroke trial design
- Regulatory risks and tight FDA timelines for novel biologics
💰 What to Pitch
- Primary: Clinical Trial Management Platform → Accelerate Phase 2b/3 study execution with real-time analytics
- Expansion: Regulatory Strategy Consulting → Mitigate approval risk and shorten FDA review cycles
🗺️ Quick Context
- HQ: Minneapolis, MN
- Employees: ≈ 50
- Rev: ≈ $2 M
- Website: diamedica.com
🤼 Competitive Intel
Which other vendors you’ll probably face to win DiaMedica’s business.
- IQVIA — CRO / Clinical Development
- Unique edge: data-driven trial design & global footprint
- Evaluated by CMO for adaptive trial insights
- Parexel — CRO / Regulatory & Trials
- Unique edge: end-to-end FDA engagement services
- Evaluated by VP Clinical for submission strategy
- LabCorp — CRO / Central Lab & Biomarkers
- Unique edge: integrated biomarker assays & imaging
- Evaluated by Dir. Translational Medicine for sample logistics
- Syneos Health — CRO / Full-Service Biopharma
- Unique edge: hybrid consulting + operational model
- Evaluated by Clinical Ops for late-stage execution
- PPD (Thermo Fisher) — CRO / Clinical Trial Ops
- Unique edge: scalable global operations
- Evaluated by VP Ops for resource flexibility
✅ Do-Now Checklist
Connect with Julie Krop on LinkedIn ([link above])
Draft email + DM focused on this DiaMedica Therapeutics Inc. sales trigger and send first touch
Schedule follow-ups in CRM (Day 3 & Day 10)
Next Step
Leverage every DiaMedica Therapeutics Inc. sales trigger to keep your pipeline full—no fluff, all action.
Subscribe to NewsletterForLeads
🧠 Copy My Prompt for Personalized Cold Outreach
────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY = ❑≈ TBD❑
OFFER_BRIEF = ❑Clinical Trial Management Platform❑
PROOF_METRIC = ❑30% faster trial execution❑
CTA_STYLE = ❑quick_call❑
TONE = ❑punchy❑
────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME = Julie
COMPANY = DiaMedica Therapeutics Inc.
DEPT = Medical
SIZE = ≈ 50
BOTTLENECK = Complexity of orphan & stroke trial design
EVENT = New CMO appointment
DETAIL = Your appointment as CMO
PAIN = Complex trial design & regulatory risk
SRC = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250806807405&div=41152219
SIM_CO = Freeline Therapeutics
WIN_METRIC = 30% faster trial execution
NEXT_SIZE = ≈ 100
EMP_EST = ≈ 50
REV_EST = ≈ $2 M
────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.
EMAIL (keep breaks):
Subject: ≈ 50-person Medical
Julie—noticed your Medical team is ≈ 50.
That’s when Complexity of orphan & stroke trial design slows growth.
We helped Freeline Therapeutics fix this with Clinical Trial Management Platform.
Result: 30% faster trial execution.
Quick call?
PS—next bottleneck hits ≈ 100.
DM ≤45 words, TONE:
Saw your post about Your appointment as CMO — Complex trial design & regulatory risk.
Clinical Trial Management Platform. 30% faster trial execution. Quick chat?